Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a...
novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(113)
•••
mjh9413
X
View Profile
View Bullboard History
Comment by
mjh9413
on Jun 07, 2022 12:22am
RE:Immunosuppresion clarification
Is the application of immunossuppressive drugs worse that the 'cure' for HU? Are drugs applied daily? Oral or injection?How many drugs (is it a cocktail)? Anyone know? Thanks.
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Comment by
Stockfshr
on Jun 06, 2022 6:49pm
RE:RE:Stock price
I prefer to focus on the positive that "immunosuppression issues have been resolved" rather than the negative that "results have been delayed due to immunosuppression issues." But
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(2)
•••
MustangSalley
X
View Profile
View Bullboard History
Comment by
MustangSalley
on Jun 06, 2022 6:14pm
RE:Stock price
We already saw the results from Ada abstract a few weeks ago. So there are no surprises except delay for the last 3 patients due to immunosuppresion issues.
(2)
•••
Runt27
X
View Profile
View Bullboard History
Post by
Runt27
on Jun 06, 2022 5:58pm
Stock price
How do you think this news will effect the stock price? Are we looking at another spike and dump? Cheers.
(29)
•••
elgin1
X
View Profile
View Bullboard History
Post by
elgin1
on Jun 06, 2022 5:48pm
Immunosuppresion clarification
I just spoke to management for clarification on the immunosuppresion. There are no issues with pouch itself . First three patients immunosuppresion was stable . Before pouch is loaded up with
...more
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Comment by
Stockfshr
on Jun 06, 2022 5:19pm
RE:RE:More POSITIVE news just out!!
I am not sure immunosuppression is continuing to have issues in the other three patients, Bio. News release states: "Three additional patients on study did not maintain optimal immunosuppression,
...more
(51)
•••
bfw
X
View Profile
View Bullboard History
Comment by
bfw
on Jun 06, 2022 5:13pm
RE:More POSITIVE news just out!!
Yeah, by all accounts, the pouch works well when immunosuppression is maintained. Lots of reasons that optimal immunosuppression not maintained: (1) Patient compliance (2) Adverse
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jun 06, 2022 4:39pm
RE:More POSITIVE news just out!!
Oh Rixy, did you even read the news? What about the other 3 who are having immunosuppression issues? And also, only one patient is off insulin for 2 years, the other one 6 months, and the
...more
(134)
•••
rixpix
X
View Profile
View Bullboard History
Post by
rixpix
on Jun 06, 2022 4:36pm
More POSITIVE news just out!!
3 patients have now been insulin independent ffor over 2 and a half years. GREAT NEWS!!
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 06, 2022 4:30pm
New Press Release - Sernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System(TM) at American Diabetes Association 82nd Scientific Sessions 2022
Researchers from the Dr. Piotr Witkowski Laboratory at the University of Chicago presented updated data on six patients with type 1 diabetes and hypoglycemia unawareness The first three patients have been insulin independent for over 2 years, 6 months, and 3 months, respectivelyThose first...
read article.
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on Jun 06, 2022 2:40pm
RE:Be patient
The only analysis that might be happening are those people that continue to vote in favor of management finally deciding to have their head examined.
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Post by
BioTeck
on Jun 06, 2022 1:51pm
Imagine Pharma
Hey Spill, call up these guys and get started on another deal. Actually tell Evotec to do it if you ever want it done. I don't know much about these cells yet but it appears they use patients
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jun 06, 2022 1:46pm
RE:Vertex news and trial update
Not to mention it took 270 days to get to insulin independance.
(2)
•••
MustangSalley
X
View Profile
View Bullboard History
Post by
MustangSalley
on Jun 06, 2022 1:11pm
Vertex news and trial update
Vertex patients results are not impressive imo. Sva has reduced H1ac1 levels from 11 to 5 , Vertex 8 to 7 I believe . Only one patient insulin independent . No mention on data of 3 rd
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >